Extensive research has indicated a strong correlation between post-translational modifications of Drp1 and prevalent chronic conditions, including neurodegenerative diseases (Bhatti et al., 2023), cardiovascular diseases (Umezu et al., 2020), and metabolic diseases (Kugler et al., 2021). This evidence concerns the gene DNM1L and Other metabolic disease.